He plays leadership roles in national and international consortia in cancer therapeutic development and cancer genomics. He has authored over 150 articles in major journals including seminal works on cancer, genomics and precision medicine. He sits on several international expert panels, advisory boards and is an international leader and expert in precision oncology.